702
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Backflow reduction in local injection therapy with gelatin formulations

, , &
Article: 2329100 | Received 10 May 2023, Accepted 29 Feb 2024, Published online: 22 Mar 2024

References

  • Allmendinger A, Mueller R, Schwarb E, et al. (2015). Measuring tissue back-pressure–in vivo injection forces during subcutaneous injection. Pharm Res 32:1–9. doi: 10.1007/s11095-014-1611-0.
  • Bhatia C, Barzilay Y, Krishna M, et al. (2006). Cement leakage in percutaneous vertebroplasty: effect of preinjection gelfoam embolization. Spine 31:915–9. doi: 10.1097/01.brs.0000209307.03930.38.
  • Birkebaek NH, Solvig J, Hansen B, et al. (2008). A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 31:e65–e65. doi: 10.2337/dc08-0977.
  • Casanova F, Carney PR, Sarntinoranont M. (2014). Effect of needle insertion speed on tissue injury, stress, and backflow distribution for convection-enhanced delivery in the rat brain. PLOS One 9:e94919. doi: 10.1371/journal.pone.0094919.
  • Casanova F, Carney PR, Sarntinoranont M. (2014). In vivo evaluation of needle force and friction stress during insertion at varying insertion speed into the brain. J Neurosci Methods 237:79–89. doi: 10.1016/j.jneumeth.2014.08.012.
  • Chaturvedi R, Wannamaker KW, Riviere PJ, et al. (2019). Real-world trends in intravitreal injection Practices among American Retina Specialists. Ophthalmol Retina 3:656–62. doi: 10.1016/j.oret.2019.03.023.
  • Cotten A, Deramond H, Cortet B, et al. (1996). Preoperative percutaneous injection of methyl methacrylate and N-butyl cyanoacrylate in vertebral hemangiomas. AJNR Am J Neuroradiol 17:137–42.
  • Day S, Acquah K, Lee PP, et al. (2011). Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am J Ophthalmol 152:1014–20. doi: 10.1016/j.ajo.2011.05.008.
  • Eom Y, Kim S, Huh J, et al. (2021). Self-sealing hyaluronic acid-coated 30-gauge intravitreal injection needles for preventing vitreous and drug reflux through needle passage. Sci Rep 11:16996. doi: 10.1038/s41598-021-96561-8.
  • Foox M, Zilberman M. (2015). Drug delivery from gelatin-based systems. Expert Opin Drug Deliv 12:1547–63. doi: 10.1517/17425247.2015.1037272.
  • Frid A, Hirsch L, Gaspar R, S.A.B.f.t.T.I.T. Workshop, et al. (2010). New injection recommendations for patients with diabetes. Diabetes Metab 36 Suppl 2:S3–S18. doi: 10.1016/S1262-3636(10)70002-1.
  • Grobben AH, Steele PJ, Somerville RA, Taylor DM. (2004). Inactivation of the bovine-spongiform-encephalopathy (BSE) agent by the acid and alkaline processes used in the manufacture of bone gelatine. Biotechnol Appl Biochem 39:329–38. doi: 10.1042/BA20030149.
  • Gupta OP, Shienbaum G, Patel AH, et al. (2010). A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology 117:2134–40. doi: 10.1016/j.ophtha.2010.02.032.
  • Hanas R, Lytzen L, Ludvigsson J. (2000). Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes. Pediatr Diabetes 1:142–9. doi: 10.1034/j.1399-5448.2000.010305.x.
  • Heise T, Nosek L, Dellweg S, et al. (2014). Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial. Diabetes Obes Metab 16:971–6. doi: 10.1111/dom.12304.
  • Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, et al. (2013). Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Des Devel Ther 7:571–83. doi: 10.2147/DDDT.S46393.
  • Ikada Y, Tabata Y. (1998). Protein release from gelatin matrices. Adv Drug Deliv Rev 31:287–301. doi: 10.1016/s0169-409x(97)00125-7.
  • Juul KA, Bengtsson H, Eyving B, et al. (2012). Influence of hypodermic needle dimensions on subcutaneous injection delivery–a pig study of injection deposition evaluated by CT scanning, histology, and backflow. Skin Res Technol 18:447–55. doi: 10.1111/j.1600-0846.2011.00592.x.
  • Kadji FMN, Kotani K, Tsukamoto H, et al. (2022). Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation. Virol J 19:94. doi: 10.1186/s12985-022-01819-w.
  • Kakudo N, Morimoto N, Ogawa T, et al. (2017). Angiogenic effect of platelet-rich plasma combined with gelatin hydrogel granules injected into murine subcutis. J Tissue Eng Regen Med 11:1941–8. doi: 10.1002/term.2091.
  • Kamakura T, Derval N, Duchateau J, et al. (2021). Vein of Marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients. Circ Arrhythm Electrophysiol 14:e010001.
  • Kimura Y, Tabata Y. (2010). Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21:37–51. doi: 10.1163/156856209X410193.
  • Koda M, Okamoto K, Miyoshi Y, Kawasaki H. (1992). Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest Radiol 17:167–9. doi: 10.1007/BF01888537.
  • Liu XW, Jin P, Wang LJ, et al. (2013). Vertebroplasty in the treatment of symptomatic vertebral haemangiomas without neurological deficit. Eur Radiol 23:2575–81. doi: 10.1007/s00330-013-2843-9.
  • Li Z, Masumoto H, Jo JI, et al. (2018). Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model. Gen Thorac Cardiovasc Surg 66:641–7. doi: 10.1007/s11748-018-0969-z.
  • Li Z, Yu K, Chang X, et al. (2020). Cement leakage following percutaneous kyphoplasty in a patient after a posterior lumbar fusion: a case report. BMC Surg 20:74. doi: 10.1186/s12893-020-00733-8.
  • Marabelle A, Andtbacka R, Harrington K, et al. (2018). Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT. Ann Oncol 29:2163–74.), doi: 10.1093/annonc/mdy423.
  • Mathaes R, Koulov A, Joerg S, Mahler HC. (2016). Subcutaneous injection volume of biopharmaceuticals-pushing the boundaries. J Pharm Sci 105:2255–9. doi: 10.1016/j.xphs.2016.05.029.
  • Matsuo T, Masumoto H, Tajima S, et al. (2015). Efficient long-term survival of cell grafts after myocardial infarction with thick viable cardiac tissue entirely from pluripotent stem cells. Sci Rep 5:16842. doi: 10.1038/srep16842.
  • Meng B, Qian M, Xia SX, et al. (2013). Biomechanical characteristics of cement/gelatin mixture for prevention of cement leakage in vertebral augmentation. Eur Spine J 22:2249–55. doi: 10.1007/s00586-013-2886-2.
  • Mitsui R, Matsukawa M, Nakagawa K, et al. (2021). Efficient cell transplantation combining injectable hydrogels with control release of growth factors. Regen Ther 18:372–83. doi: 10.1016/j.reth.2021.09.003.
  • Morhard R, Mueller JL, Tang Q, et al. (2020). Understanding factors governing distribution volume of ethyl cellulose-ethanol to optimize ablative therapy in the liver. IEEE Trans Biomed Eng 67:2337–48. doi: 10.1109/TBME.2019.2960049.
  • Morhard R, Nief C, Barrero Castedo C, et al. (2017). Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. Sci Rep 7:8750. doi: 10.1038/s41598-017-09371-2.
  • Muñoz NM, Williams M, Dixon K, et al. (2021). Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer 9:e001800. doi: 10.1136/jitc-2020-001800.
  • Nahar M, Mishra D, Dubey V, Jain NK. (2008). Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine 4:252–61. doi: 10.1016/j.nano.2008.03.007.
  • Nii T. (2021). Strategies using gelatin microparticles for regenerative therapy and drug screening applications. Molecules 26:6795. doi: 10.3390/molecules26226795.
  • Park S, Kim J, Lee C. (2022). Injectable rapidly dissolving needle-type gelatin implant capable of delivering high concentrations of H2O2 through intratumoral injection. Biomed Pharmacother 156:113910. doi: 10.1016/j.biopha.2022.113910.
  • Præstmark KA, Stallknecht B, Jensen ML, et al. (2016). Injection technique and pen needle design affect leakage from skin after subcutaneous injections. J Diabetes Sci Technol 10:914–22. doi: 10.1177/1932296815626723.
  • Premat K, Clarençon F, Cormier É, et al. (2017). Long-term outcome of percutaneous alcohol embolization combined with percutaneous vertebroplasty in aggressive vertebral hemangiomas with epidural extension. Eur Radiol 27:2860–7. doi: 10.1007/s00330-016-4664-0.
  • Ryu M, Shimamura Y, Kinoshita T, et al. (1997). Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 27:251–7. doi: 10.1093/jjco/27.4.251.
  • Schmidt R, Cakir B, Mattes T, et al. (2005). Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J 14:466–73. doi: 10.1007/s00586-004-0839-5.
  • Seki T, Nonaka T, Kubota Y, et al. (1989). Ultrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol 84:1400–7.
  • Sheth RA, Murthy R, Hong DS, et al. (2020). Assessment of image-guided intratumoral delivery of immunotherapeutics in patients with cancer. JAMA Netw Open 3:e207911. doi: 10.1001/jamanetworkopen.2020.7911.
  • Shiina S, Tagawa K, Unuma T, et al. (1991). Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 68:1524–30. doi: 10.1002/1097-0142(19911001)68:7<1524::AID-CNCR2820680711>3.0.CO;2-O.
  • Shokry M, Hathout RM, Mansour S. (2018). Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: augmented in-vivo efficacy and safe histological profile. Int J Pharm 545:229–39. doi: 10.1016/j.ijpharm.2018.04.059.
  • Tamura H, Goto R, Akune Y, et al. (2015). the clinical effectiveness and cost-effectiveness of screening for age-related macular degeneration in Japan: a Markov modeling study. PLOS One 10:e0133628. doi: 10.1371/journal.pone.0133628.
  • Walker C, Thelen J. Livestock Injection methods & placement, ANR Communications and Marketing ((2016). http://anrcom.msu.edu/) for MSU Extension (http://msue.anr.msu.edu/).
  • Will RG, Ironside JW, Zeidler M, et al. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–5. doi: 10.1016/s0140-6736(96)91412-9.
  • Wilson DJ, Neuringer M, Stoddard J, et al. (2017). Subretinal cell-based therapy: an analysis of surgical variables to increase cell survival. Retina 37:2162–6. doi: 10.1097/IAE.0000000000001462.
  • Xu W, Lan Z, Huang Y. (2020). Intraoperative injection of absorbable gelatin sponge (AGS) mixed with cement followed by spinal decompression to treat elderly with vertebral hemangiomas. BMC Musculoskelet Disord 21:125. doi: 10.1186/s12891-020-3143-6.
  • Young S, Wong M, Tabata Y, Mikos AG. (2005). Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109:256–74. doi: 10.1016/j.jconrel.2005.09.023.